PVQ — Rickettsia Spp. Nucleic Acid Based Detection Assay Class II

FDA Device Classification

FDA product code PVQ covers "Rickettsia Spp. Nucleic Acid Based Detection Assay", a Class II medical device regulated under 21 CFR 866.3316. Submissions are reviewed by the Microbiology panel. At least 1 recent 510(k) clearance has been granted under this product code.

Classification Details

Product Code
PVQ
Device Class
Class II
Regulation Number
866.3316
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

An in vitro diagnostic test for the detection of Rickettsia spp. nucleic acids in specimens from individuals with signs or symptoms of rickettsial infection and epidemiological risk factors consistent with potential exposure. Test results are used in conjunction with other diagnostic assays and clinical observations to aid in the diagnosis infection, in accordance with criteria defined by the appropriate public health authorities in the Federal government.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K170940centers for disease control and prevention (cdc)Rickettsia Real-time PCR AssayJune 29, 2017